Avenue Therapeutics Stock Market Value
| ATXI Stock | USD 2.08 0.07 3.48% |
| Symbol | Avenue |
Avenue Therapeutics Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avenue Therapeutics. If investors know Avenue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avenue Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share 24.78 | Return On Assets (2.01) | Return On Equity (5.35) |
The market value of Avenue Therapeutics is measured differently than its book value, which is the value of Avenue that is recorded on the company's balance sheet. Investors also form their own opinion of Avenue Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Avenue Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avenue Therapeutics' market value can be influenced by many factors that don't directly affect Avenue Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avenue Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avenue Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avenue Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Avenue Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Avenue Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Avenue Therapeutics.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Avenue Therapeutics on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Avenue Therapeutics or generate 0.0% return on investment in Avenue Therapeutics over 30 days. Avenue Therapeutics is related to or competes with Capricor Therapeutics, Soleno Therapeutics, Bio Path, Moleculin Biotech, Crinetics Pharmaceuticals, Assembly Biosciences, and Instil Bio. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in... More
Avenue Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Avenue Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Avenue Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 23.22 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 6.81 |
Avenue Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avenue Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Avenue Therapeutics' standard deviation. In reality, there are many statistical measures that can use Avenue Therapeutics historical prices to predict the future Avenue Therapeutics' volatility.| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.44) | |||
| Total Risk Alpha | (1.16) | |||
| Treynor Ratio | 4.39 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avenue Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Avenue Therapeutics Backtested Returns
Avenue Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0458, which signifies that the company had a -0.0458% return per unit of standard deviation over the last 3 months. Avenue Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Avenue Therapeutics' risk adjusted performance of (0.07), and Mean Deviation of 3.32 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.1, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Avenue Therapeutics are expected to decrease at a much lower rate. During the bear market, Avenue Therapeutics is likely to outperform the market. At this point, Avenue Therapeutics has a negative expected return of -0.2%. Please make sure to confirm Avenue Therapeutics' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Avenue Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.26 |
Weak reverse predictability
Avenue Therapeutics has weak reverse predictability. Overlapping area represents the amount of predictability between Avenue Therapeutics time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Avenue Therapeutics price movement. The serial correlation of -0.26 indicates that nearly 26.0% of current Avenue Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.26 | |
| Spearman Rank Test | -0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Avenue Therapeutics lagged returns against current returns
Autocorrelation, which is Avenue Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Avenue Therapeutics' stock expected returns. We can calculate the autocorrelation of Avenue Therapeutics returns to help us make a trade decision. For example, suppose you find that Avenue Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Avenue Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Avenue Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Avenue Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Avenue Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Avenue Therapeutics Lagged Returns
When evaluating Avenue Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Avenue Therapeutics stock have on its future price. Avenue Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Avenue Therapeutics autocorrelation shows the relationship between Avenue Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Avenue Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Avenue Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Avenue Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Avenue Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Avenue Therapeutics Stock:Check out Avenue Therapeutics Correlation, Avenue Therapeutics Volatility and Avenue Therapeutics Alpha and Beta module to complement your research on Avenue Therapeutics. For more detail on how to invest in Avenue Stock please use our How to Invest in Avenue Therapeutics guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Avenue Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.